LOINC
Version 2.67

63346-1Sjogrens syndrome-A extractable nuclear Ab [Presence] in Body fluid by Immune diffusion (ID)Active

Part Descriptions

LP16760-8   Sjogrens syndrome-A extractable nuclear
Sjogren syndrome type A antigen (also known as SS-A, Ro, and E3 ubiquitin-protein ligase TRIM21) and Sjogren syndrome type B antigen (also known as SS-B and Lupus La protein) are nuclear antigens to which autoantibodies develop in autoimmune disorders such as Sjogren's syndrome (SS) and systemic lupus erythematosus (SLE). Between 40 and 70% of patients with SS have anti-SSA and/or anti-SSB autoantibodies, and 30-40% and 10-15% of patients with SLE are anti-SSA and anti-SSB positive, respectively. Longitudinal studies have shown that anti-SSA and -SSB antibodies may be present up to 20 years before the clinical onset of disease. SS patients who are anti-SSA and anti-SSB positive may have longer disease duration, parotid gland enlargement, decreased salivary flow, more severe minor salivary gland infiltration and a higher prevalence of extraglandular manifestations. [PMID: 27184054] Source: Regenstrief LOINC, PMID: 27184054

LP7238-1   Body fld
The LOINC "Body fld" System represents any body fluid that does not already have its own named System in LOINC, such as cochlear fluid or chyle. "Body fld" is not a high-level concept that includes all body fluids. Source: Regenstrief LOINC, PMID: 27184054

Fully-Specified Name

Component
Sjogrens syndrome-A extractable nuclear Ab
Property
PrThr
Time
Pt
System
Body fld
Scale
Ord
Method
Immune diffusion

Additional Names

Short Name
ENA SS-A Ab Fld Ql ID
Display Name
Sjogrens syndrome-A extractable nuclear Ab Immune diff Ql (Body fld)

Basic Attributes

Class
SERO
Type
Laboratory
First Released
Version 2.36
Last Updated
Version 2.56
Change Reason
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both

Member of these Groups

LG26780-3 Sjogrens syndrome-A extractable nuclear Ab|PrThr|Pt|Body fld

Language Variants Get Info

zh-CNChinese (CHINA)
Sjogrens 综合征-a 可提取性核 抗体:存在情况或阈值:时间点:体液:序数型:免疫扩散法
nl-NLDutch (NETHERLANDS)
SS-A extraheerbare nucleaire As:aanwezigheid:moment:lichaamsvocht:ordinaal:immunodiffusie
fr-BEFrench (BELGIUM)
Syndrome de Sjögren-a nucléaire soluble Ac:PrThr:Temps ponctuel:Liquide biologique:Ordinal:Immunodiffusion
fr-CAFrench (CANADA)
Syndrome de Sjögren-a nucléaire soluble , Ac:Présence-Seuil:Temps ponctuel:Liquide biologique:Ordinal:Immunodiffusion
fr-FRFrench (FRANCE)
SSA/Ro anticorps:Présence/Seuil:Ponctuel:Liquide biologique:Qualitatif:Immunodiffusion
it-ITItalian (ITALY)
Sjogren, sindrome-nucleare estraibile A , Ab:PrThr:Pt:Liquido corporeo:Ord:Immuno diffusione
ru-RURussian (RUSSIAN FEDERATION)
Шегрена синдром-A экстрагируемый ядерный Ат:PrThr:ТчкВрм:Тело ждк:Пор:Иммунодиффузия
es-ESSpanish (SPAIN)
Antígeno nuclear extraíble Síndrome de Sjogren-A (SS-A) Anticuerpos:PrThr:Punto temporal:Fluido corporal:Ord:Inmunodifusión
tr-TRTurkish (TURKEY)
Sjögrens sendromu-A özütlenebilir nükleer Ab:MevcEşik:Zmlı:Vücut sv:Srl:İmmün difüzyon

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=63346-1